Becton, Dickinson and Company to Invest $20 Million Into Utah Facility
Becton Dickinson (NYSE:BDX) is marking 60 years at its facility in Sandy, Utah, by pledging a $20 million upgrade to the facility, which makes IV catheters and valves, blood collection devices and surgical products.
BD said it bought the site dates back to Deseret Pharmaceutical, which opened in Murray, Utah, in 1956. Franklin Lakes, N.J.-based BD bought the plant in in 1986 and grew it to 550,000 square feet and 1,200 employees.
“Our Sandy facility is one of the largest and longest-running manufacturing sites across all of BD,” BD Medical president Tom Polen said in prepared remarks.
BD said it bought the site dates back to Deseret Pharmaceutical, which opened in Murray, Utah, in 1956. Franklin Lakes, N.J.-based BD bought the plant in in 1986 and grew it to 550,000 square feet and 1,200 employees.
“Our Sandy facility is one of the largest and longest-running manufacturing sites across all of BD,” BD Medical president Tom Polen said in prepared remarks.